Bihua Chen, 10% Owner, Director, on August 06, 2026, executed a purchase for 312,500 shares in BlossomHill Therapeutics (BLSM) for $5,000,000. Following the Form 4 filing with the SEC, Chen has control over a total of 3,614,034 common shares of the company, with 3,614,034 controlled indirectly.
SEC Filing: